Envista (NYSE:NVST) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Envista (NYSE:NVST - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.04, Zacks reports. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The company's revenue was down 1.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.26 earnings per share. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Stock Up 3.9 %

NVST stock traded up $0.63 during midday trading on Friday, hitting $16.97. 3,541,451 shares of the company's stock were exchanged, compared to its average volume of 2,527,319. Envista has a 12-month low of $14.22 and a 12-month high of $23.00. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $2.88 billion, a price-to-earnings ratio of -2.61, a price-to-earnings-growth ratio of 1.27 and a beta of 1.12. The firm has a 50 day moving average price of $16.73 and a 200-day moving average price of $19.05.

Analyst Upgrades and Downgrades

Several analysts have recently commented on NVST shares. JPMorgan Chase & Co. reduced their price target on shares of Envista from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Thursday, March 6th. Wells Fargo & Company set a $19.00 price objective on Envista in a research report on Saturday, March 8th. Morgan Stanley set a $16.00 target price on shares of Envista in a report on Tuesday, April 15th. UBS Group decreased their target price on Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Monday, March 10th. Finally, New Street Research set a $19.00 target price on Envista in a report on Thursday, March 6th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $20.18.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.